FDA advisers vote against sleep peptide as they debate safety and health claims
MarketWatch · C · trust 48/100
The FDA’s advisory committee is meeting for two days to discuss whether seven peptides — which have become popular in wellness circles — should be allowed to be compounded.
Read the original at MarketWatch →
Open in TruthVane →